BXRX Insider Trading Activity and SEC Form 4 Filings
BXRX insider trading summary
No open-market insider purchases or sales of Baudax Bio, Inc. (BXRX) have been reported on SEC Form 4 in the past 12 months.
Latest BXRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 15, 2022 | Geraldine Henwood | President and CEO | Buy | $3K (1,200 @ $2.55) |
| Sep 22, 2021 | Geraldine Henwood | President and CEO | Buy | $5K (8,200 @ $0.59) |
| Aug 31, 2021 | Winston J Churchill | Director | Buy | $63K (100,000 @ $0.63) |
| Aug 20, 2021 | Richard S Casten | Chief Financial Officer | Buy | $26K (50,000 @ $0.51) |
| Jun 7, 2021 | Winston J Churchill | Director | Buy | $12K (15,000 @ $0.78) |
| Jun 7, 2021 | Winston J Churchill | Director | Buy | $8K (10,000 @ $0.78) |
| May 14, 2021 | Richard S Casten | Chief Financial Officer | Buy | $20K (25,000 @ $0.79) |
| May 11, 2021 | Arnold M Baskies | Director | Buy | $8K (10,000 @ $0.82) |
| May 7, 2021 | Geraldine Henwood | President and CEO | Buy | $5K (6,000 @ $0.83) |
| Mar 15, 2021 | Richard S Casten | Chief Financial Officer | Buy | $35K (25,000 @ $1.41) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.